Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-27

Clinical Trial Update: RHYTHM (Formerly Escape II Myocardium) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for RHYTHM (Escape II Myocardium) completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RHYTHM

Snippet

Sponsor: Columbia University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2020-11-27